An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

Summary

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).

Timeline

Start

2025-04-09

Primary completion

2026-11-01

Completion

2029-11-01

Drugs

Indications